Cargando…
Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects
Thyroxine metabolism is an important topic of pathogenesis research and treatment schedule of subclinical hypothyroidism (SCH). L-Thyroxine replacement therapy (LRT) is usually recommended for severe SCH patients only. Our previous studies reported that disordered serum lipid of mild SCH people coul...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531258/ https://www.ncbi.nlm.nih.gov/pubmed/33072620 http://dx.doi.org/10.3389/fcimb.2020.00495 |
_version_ | 1783589728150355968 |
---|---|
author | Yao, Zhenyu Zhao, Meng Gong, Ying Chen, Wenbin Wang, Qian Fu, Yilin Guo, Tian Zhao, Jiajun Gao, Ling Bo, Tao |
author_facet | Yao, Zhenyu Zhao, Meng Gong, Ying Chen, Wenbin Wang, Qian Fu, Yilin Guo, Tian Zhao, Jiajun Gao, Ling Bo, Tao |
author_sort | Yao, Zhenyu |
collection | PubMed |
description | Thyroxine metabolism is an important topic of pathogenesis research and treatment schedule of subclinical hypothyroidism (SCH). L-Thyroxine replacement therapy (LRT) is usually recommended for severe SCH patients only. Our previous studies reported that disordered serum lipid of mild SCH people could also benefit from LRT. However, the benefits were different among individuals, as shown by the variations in drug dosage that required to maintain thyroid-stimulating hormone (TSH) stability. Alternative pathways, such as sulfation and glucuronidation of iodothyronine, may play a role in thyroid hormones metabolism in peripheral tissues aside from thyroid. Conjugated thyroxine can be hydrolyzed and reused in tissues including gastrointestinal tract, in which gut microbiota are one of the most attractive physiological components. On this site, the roles of gut microbiota in thyroidal metabolism should be valued. In this study, a cross-sectional study was performed by analyzing 16S rDNA of gut microbiota in mild SCH patients treated with L-thyroxine or not. Subjects were divided by serum lipid level, L-thyroxine treatment, or L-thyroxine dosage, respectively. Relationship between gut microbiome and serum profile, L-thyroxine treatment, and dose were discussed. Other metabolic disorders such as type 2 diabetes and hypertension were also taken into consideration. It turned out that microbiome varied among individuals divided by dose and the increment of L-thyroxine but not by serum lipid profile. Relative abundance of certain species that were associated with thyroxine metabolism were found varied among different L-thyroxine doses although in relatively low abundance. Moreover, serum cholesterol may perform relevance effects with L-thyroxine in shaping microbiome. Our findings suggested that the differences in L-thyroxine dosage required to maintain TSH level stability, as well as the SCH development, which was displayed by the increased L-thyroxine doses in subsequent follow-up, had relationship with gut microbial composition. The reason may due to the differences in thyroxine metabolic capacity in gut. In addition, the metabolic similarity of iodothyronines and bile acid in gut also provides possibilities for the correlation between host's thyroxine and cholesterol levels. This study was registered with ClinicalTrials.gov as number NCT01848171. |
format | Online Article Text |
id | pubmed-7531258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75312582020-10-17 Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects Yao, Zhenyu Zhao, Meng Gong, Ying Chen, Wenbin Wang, Qian Fu, Yilin Guo, Tian Zhao, Jiajun Gao, Ling Bo, Tao Front Cell Infect Microbiol Cellular and Infection Microbiology Thyroxine metabolism is an important topic of pathogenesis research and treatment schedule of subclinical hypothyroidism (SCH). L-Thyroxine replacement therapy (LRT) is usually recommended for severe SCH patients only. Our previous studies reported that disordered serum lipid of mild SCH people could also benefit from LRT. However, the benefits were different among individuals, as shown by the variations in drug dosage that required to maintain thyroid-stimulating hormone (TSH) stability. Alternative pathways, such as sulfation and glucuronidation of iodothyronine, may play a role in thyroid hormones metabolism in peripheral tissues aside from thyroid. Conjugated thyroxine can be hydrolyzed and reused in tissues including gastrointestinal tract, in which gut microbiota are one of the most attractive physiological components. On this site, the roles of gut microbiota in thyroidal metabolism should be valued. In this study, a cross-sectional study was performed by analyzing 16S rDNA of gut microbiota in mild SCH patients treated with L-thyroxine or not. Subjects were divided by serum lipid level, L-thyroxine treatment, or L-thyroxine dosage, respectively. Relationship between gut microbiome and serum profile, L-thyroxine treatment, and dose were discussed. Other metabolic disorders such as type 2 diabetes and hypertension were also taken into consideration. It turned out that microbiome varied among individuals divided by dose and the increment of L-thyroxine but not by serum lipid profile. Relative abundance of certain species that were associated with thyroxine metabolism were found varied among different L-thyroxine doses although in relatively low abundance. Moreover, serum cholesterol may perform relevance effects with L-thyroxine in shaping microbiome. Our findings suggested that the differences in L-thyroxine dosage required to maintain TSH level stability, as well as the SCH development, which was displayed by the increased L-thyroxine doses in subsequent follow-up, had relationship with gut microbial composition. The reason may due to the differences in thyroxine metabolic capacity in gut. In addition, the metabolic similarity of iodothyronines and bile acid in gut also provides possibilities for the correlation between host's thyroxine and cholesterol levels. This study was registered with ClinicalTrials.gov as number NCT01848171. Frontiers Media S.A. 2020-09-18 /pmc/articles/PMC7531258/ /pubmed/33072620 http://dx.doi.org/10.3389/fcimb.2020.00495 Text en Copyright © 2020 Yao, Zhao, Gong, Chen, Wang, Fu, Guo, Zhao, Gao and Bo. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Yao, Zhenyu Zhao, Meng Gong, Ying Chen, Wenbin Wang, Qian Fu, Yilin Guo, Tian Zhao, Jiajun Gao, Ling Bo, Tao Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects |
title | Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects |
title_full | Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects |
title_fullStr | Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects |
title_full_unstemmed | Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects |
title_short | Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects |
title_sort | relation of gut microbes and l-thyroxine through altered thyroxine metabolism in subclinical hypothyroidism subjects |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531258/ https://www.ncbi.nlm.nih.gov/pubmed/33072620 http://dx.doi.org/10.3389/fcimb.2020.00495 |
work_keys_str_mv | AT yaozhenyu relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT zhaomeng relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT gongying relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT chenwenbin relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT wangqian relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT fuyilin relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT guotian relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT zhaojiajun relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT gaoling relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects AT botao relationofgutmicrobesandlthyroxinethroughalteredthyroxinemetabolisminsubclinicalhypothyroidismsubjects |